BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23288701)

  • 1. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.
    Kobos R; Nagai M; Tsuda M; Merl MY; Saito T; Laé M; Mo Q; Olshen A; Lianoglou S; Leslie C; Ostrovnaya I; Antczak C; Djaballah H; Ladanyi M
    J Pathol; 2013 Apr; 229(5):743-754. PubMed ID: 23288701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
    Martignoni G; Gobbo S; Camparo P; Brunelli M; Munari E; Segala D; Pea M; Bonetti F; Illei PB; Netto GJ; Ladanyi M; Chilosi M; Argani P
    Mod Pathol; 2011 Oct; 24(10):1313-9. PubMed ID: 21602817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
    Tsuji K; Ishikawa Y; Imamura T
    Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.
    Tsuda M; Davis IJ; Argani P; Shukla N; McGill GG; Nagai M; Saito T; Laé M; Fisher DE; Ladanyi M
    Cancer Res; 2007 Feb; 67(3):919-29. PubMed ID: 17283122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.
    Tanaka M; Chuaychob S; Homme M; Yamazaki Y; Lyu R; Yamashita K; Ae K; Matsumoto S; Kumegawa K; Maruyama R; Qu W; Miyagi Y; Yokokawa R; Nakamura T
    Nat Commun; 2023 Apr; 14(1):1957. PubMed ID: 37029109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
    Aulmann S; Longerich T; Schirmacher P; Mechtersheimer G; Penzel R
    Histopathology; 2007 Jun; 50(7):881-6. PubMed ID: 17543078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97.
    Pozner A; Li L; Verma SP; Wang S; Barrott JJ; Nelson ML; Yu JSE; Negri GL; Colborne S; Hughes CS; Zhu JF; Lambert SL; Carroll LS; Smith-Fry K; Stewart MG; Kannan S; Jensen B; John CM; Sikdar S; Liu H; Dang NH; Bourdage J; Li J; Vahrenkamp JM; Mortenson KL; Groundland JS; Wustrack R; Senger DL; Zemp FJ; Mahoney DJ; Gertz J; Zhang X; Lazar AJ; Hirst M; Morin GB; Nielsen TO; Shen PS; Jones KB
    Nat Commun; 2024 Feb; 15(1):1165. PubMed ID: 38326311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar Soft Part Sarcoma.
    Jaber OI; Kirby PA
    Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
    Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
    Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?
    Chai J; Ma J; Liu Y; Zhao D; Yin Z; Wang Z; Fan L
    Pathology; 2023 Apr; 55(3):416-419. PubMed ID: 36104270
    [No Abstract]   [Full Text] [Related]  

  • 12. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lingual Alveolar Soft Part Sarcoma in a 1-Year-Old Infant: Youngest Reported Case With Characteristic ASPSCR1-TFE3 Fusion.
    Ruffle A; Cameron M; Jonas N; Levine S; Mills C; Hook CE; Murray MJ
    Pediatr Dev Pathol; 2019; 22(4):391-395. PubMed ID: 30744536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.
    Ju X; Sun K; Liu R; Li S; Abulajiang G; Zou H; Lan J; Ren Y; Jiang J; Liang W; Pang L; Li F
    Pathol Oncol Res; 2018 Jul; 24(3):593-600. PubMed ID: 28766250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
    Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
    J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
    Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
    Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment.
    Goodwin ML; Jin H; Straessler K; Smith-Fry K; Zhu JF; Monument MJ; Grossmann A; Randall RL; Capecchi MR; Jones KB
    Cancer Cell; 2014 Dec; 26(6):851-862. PubMed ID: 25453902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
    Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.